Dylan Nagy
Overview
Explore the profile of Dylan Nagy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
15
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Drake C, Nagy D, Meiselbach M, Zhu J, Saloner B, Stein B, et al.
J Addict Med
. 2024 Jun;
18(3):335-338.
PMID: 38833558
Objectives: Overdose mortality has risen most rapidly among racial and ethnic minority groups while buprenorphine prescribing has increased disproportionately in predominantly non-Hispanic White urban areas. To identify whether buprenorphine availability...
2.
Charlesworth C, Nagy D, Drake C, Manibusan B, Zhu J
J Rural Health
. 2023 Apr;
40(1):16-25.
PMID: 37088967
Objective: Medicaid enrollees in rural and frontier areas face inadequate access to mental health services, but the extent to which access varies for different provider types is unknown. We assessed...
3.
Meiselbach M, Drake C, Zhu J, Manibusan B, Nagy D, Sorbero M, et al.
Med Care Res Rev
. 2023 Apr;
80(4):423-432.
PMID: 37083043
Provider networks in Medicaid Managed Care (MMC) play a crucial role in ensuring access to buprenorphine, a highly effective treatment for opioid use disorder. Using a difference-in-differences approach that compares...
4.
Goldstein T, Saul M, Nagy D, Sylvester R, Rode N, Donohue J
Psychiatr Serv
. 2022 Apr;
73(10):1123-1131.
PMID: 35414190
Objective: Early-onset bipolar disorder is among the costliest psychiatric disorders; yet inpatient and outpatient service use patterns in this group are largely unknown. One-year behavioral and medical health service use...
5.
Drake C, Nagy D, Nguyen T, Kraemer K, Mair C, Wallace D, et al.
Health Serv Res
. 2021 Jul;
56(5):777-787.
PMID: 34250592
Objective: To compare measures of spatial access to care commonly used by policy makers and researchers with the more comprehensive enhanced two-step floating catchment area (E2SFCA) method. Study Setting: Fourteen...
6.
Cochran G, Cole E, Sharbaugh M, Nagy D, Gordon A, Gellad W, et al.
J Addict Med
. 2021 May;
16(2):e87-e96.
PMID: 33973921
Objectives: Limited information is available regarding provider- and patient panel-level factors associated with primary care provider (PCP) adoption/prescribing of medication for opioid use disorder (MOUD). Methods: We assessed a retrospective...
7.
Cole E, Drake C, DiDomenico E, Sharbaugh M, Kim J, Nagy D, et al.
Drug Alcohol Depend
. 2021 Feb;
221:108633.
PMID: 33631544
Background: Many persons with opioid use disorder (OUD) initiate medication for opioid use disorder (MOUD) with one clinic and switch to another clinic during their course of treatment. These switches...